Abstract
Integrated testing for TB and COVID-19 may help find those TB patients who are not accessing care in the context of the COVID-19 pandemic. Some molecular platforms with assays for both diseases are already commercially available; however, integrated testing approaches need to be systematically evaluated to ensure their appropriate implementation.
| Original language | English |
|---|---|
| Pages (from-to) | 162-166 |
| Number of pages | 5 |
| Journal | Med |
| Volume | 3 |
| Issue number | 3 |
| DOIs |
|
| State | Published - 11 Mar 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Integrated testing for TB and COVID-19'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver